Take Solutions Limited (TAKE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Take Solutions Limited (TAKE) has a cash flow conversion efficiency ratio of -0.122x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-31.39 Million ≈ $-339.47K USD) by net assets (Rs256.29 Million ≈ $2.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Take Solutions Limited (TAKE) liquidity interval to measure how many days the company can operate on defensive assets alone.
Take Solutions Limited - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Take Solutions Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Take Solutions Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Take Solutions Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
European Metals Holdings Ltd
AU:EMH
|
-0.036x |
|
EM-Tech.CO. LTD
KQ:091120
|
0.018x |
|
Changhae Ethanol Co. Ltd
KQ:004650
|
0.102x |
|
Thomas Scott (India) Limited
NSE:THOMASCOTT
|
-0.146x |
|
Airmate Cayman International Co Ltd
TW:1626
|
-0.074x |
|
Kristal Kola ve Mesrubat Sanayi Ticaret AS
IS:KRSTL
|
0.061x |
|
PB Bankshares Inc
NASDAQ:PBBK
|
0.015x |
|
Europacorp
PA:ALECP
|
-1.972x |
Annual Cash Flow Conversion Efficiency for Take Solutions Limited (2007–2025)
The table below shows the annual cash flow conversion efficiency of Take Solutions Limited from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see TAKE stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs205.27 Million ≈ $2.22 Million |
Rs-163.66 Million ≈ $-1.77 Million |
-0.797x | +24.06% |
| 2024-03-31 | Rs-88.73 Million ≈ $-959.58K |
Rs93.16 Million ≈ $1.01 Million |
-1.050x | -669.68% |
| 2023-03-31 | Rs1.09 Billion ≈ $11.74 Million |
Rs200.16 Million ≈ $2.16 Million |
0.184x | +12.40% |
| 2022-03-31 | Rs1.81 Billion ≈ $19.53 Million |
Rs296.17 Million ≈ $3.20 Million |
0.164x | +36.32% |
| 2021-03-31 | Rs11.24 Billion ≈ $121.59 Million |
Rs1.35 Billion ≈ $14.63 Million |
0.120x | -9.68% |
| 2020-03-31 | Rs15.85 Billion ≈ $171.45 Million |
Rs2.11 Billion ≈ $22.83 Million |
0.133x | +96.40% |
| 2019-03-31 | Rs15.27 Billion ≈ $165.18 Million |
Rs1.04 Billion ≈ $11.20 Million |
0.068x | -25.00% |
| 2018-03-31 | Rs13.37 Billion ≈ $144.56 Million |
Rs1.21 Billion ≈ $13.07 Million |
0.090x | +54.17% |
| 2017-03-31 | Rs9.53 Billion ≈ $103.08 Million |
Rs558.98 Million ≈ $6.05 Million |
0.059x | -73.41% |
| 2016-03-31 | Rs6.72 Billion ≈ $72.62 Million |
Rs1.48 Billion ≈ $16.02 Million |
0.221x | +72.74% |
| 2015-03-31 | Rs5.80 Billion ≈ $62.78 Million |
Rs741.25 Million ≈ $8.02 Million |
0.128x | -33.69% |
| 2014-03-31 | Rs5.18 Billion ≈ $56.06 Million |
Rs998.25 Million ≈ $10.80 Million |
0.193x | -23.03% |
| 2013-03-31 | Rs4.66 Billion ≈ $50.41 Million |
Rs1.17 Billion ≈ $12.61 Million |
0.250x | -17.75% |
| 2012-03-31 | Rs3.80 Billion ≈ $41.05 Million |
Rs1.15 Billion ≈ $12.49 Million |
0.304x | +45.36% |
| 2011-03-31 | Rs2.82 Billion ≈ $30.48 Million |
Rs589.85 Million ≈ $6.38 Million |
0.209x | +341.83% |
| 2010-03-31 | Rs3.86 Billion ≈ $41.70 Million |
Rs182.63 Million ≈ $1.98 Million |
0.047x | -72.58% |
| 2009-03-31 | Rs3.86 Billion ≈ $41.73 Million |
Rs666.62 Million ≈ $7.21 Million |
0.173x | +1.88% |
| 2008-03-31 | Rs2.98 Billion ≈ $32.28 Million |
Rs506.13 Million ≈ $5.47 Million |
0.170x | +25.11% |
| 2007-03-31 | Rs885.44 Million ≈ $9.58 Million |
Rs120.02 Million ≈ $1.30 Million |
0.136x | -- |
About Take Solutions Limited
TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services in life sciences and software and information technology in India. The company offers clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance and safety services backed by technology expertise. It also provides embed digital and employ mobile solutions for patient c… Read more